Cargando…
“Weakly Ligated, Labile Ligand” Nanoparticles: The Case of Ir(0)(n)·(H(+)Cl(–))(m)
[Image: see text] It is of considerable interest to prepare weakly ligated, labile ligand (WLLL) nanoparticles for applications in areas such as chemical catalysis. WLLL nanoparticles can be defined as nanoparticles with sufficient, albeit minimal, surface ligands of moderate binding strength to met...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643726/ https://www.ncbi.nlm.nih.gov/pubmed/31458138 http://dx.doi.org/10.1021/acsomega.8b01569 |
_version_ | 1783437155953016832 |
---|---|
author | Mondloch, Joseph E. Özkar, Saim Finke, Richard G. |
author_facet | Mondloch, Joseph E. Özkar, Saim Finke, Richard G. |
author_sort | Mondloch, Joseph E. |
collection | PubMed |
description | [Image: see text] It is of considerable interest to prepare weakly ligated, labile ligand (WLLL) nanoparticles for applications in areas such as chemical catalysis. WLLL nanoparticles can be defined as nanoparticles with sufficient, albeit minimal, surface ligands of moderate binding strength to meta-stabilize nanoparticles, initial stabilizer ligands that can be readily replaced by other, desired, more strongly coordinating ligands and removed completely when desired. Herein, we describe WLLL nanoparticles prepared from [Ir(1,5-COD)Cl](2) reduction under H(2), in acetone. The results suggest that H(+)Cl(–)-stabilized Ir(0)(n) nanoparticles, herein Ir(0)(n)·(H(+)Cl(–))(a), serve as a WLLL nanoparticle for the preparation of, as illustrative examples, five specific nanoparticle products: Ir(0)(n)·(Cl(–)Bu(3)NH(+))(a), Ir(0)(n)·(Cl(–)Dodec(3)NH(+))(a), Ir(0)(n)·(POct(3))(0.2n)(Cl(–)H(+))(b), Ir(0)(n)·(POct(3))(0.2n), and the γ-Al(2)O(3)-supported heterogeneous catalyst, Ir(0)(n)·(γ-Al(2)O(3))(a)(Cl(–)H(+))(b). (where a and b vary for the differently ligated nanoparticles; in addition, solvent can be present as a nanoparticle surface ligand). With added POct(3) as a key, prototype example, an important feature is that a minimum, desired, experimentally determinable amount of ligand (e.g., just 0.2 equiv POct(3) per mole of Ir) can be added, which is shown to provide sufficient stabilization that the resultant Ir(0)(n)·(POct(3))(0.2n)(Cl(–)H(+))(b) is isolable. Additionally, the initial labile ligand stabilizer HCl can be removed to yield Ir(0)(n)·(POct(3))(0.2n) that is >99% free of Cl(–) by a AgCl precipitation test. The results provide strong support for the weakly ligated, labile ligand nanoparticle concept and specific support for Ir(0)(n)·(H(+)Cl(–))(a) as a WLLL nanoparticle. |
format | Online Article Text |
id | pubmed-6643726 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-66437262019-08-27 “Weakly Ligated, Labile Ligand” Nanoparticles: The Case of Ir(0)(n)·(H(+)Cl(–))(m) Mondloch, Joseph E. Özkar, Saim Finke, Richard G. ACS Omega [Image: see text] It is of considerable interest to prepare weakly ligated, labile ligand (WLLL) nanoparticles for applications in areas such as chemical catalysis. WLLL nanoparticles can be defined as nanoparticles with sufficient, albeit minimal, surface ligands of moderate binding strength to meta-stabilize nanoparticles, initial stabilizer ligands that can be readily replaced by other, desired, more strongly coordinating ligands and removed completely when desired. Herein, we describe WLLL nanoparticles prepared from [Ir(1,5-COD)Cl](2) reduction under H(2), in acetone. The results suggest that H(+)Cl(–)-stabilized Ir(0)(n) nanoparticles, herein Ir(0)(n)·(H(+)Cl(–))(a), serve as a WLLL nanoparticle for the preparation of, as illustrative examples, five specific nanoparticle products: Ir(0)(n)·(Cl(–)Bu(3)NH(+))(a), Ir(0)(n)·(Cl(–)Dodec(3)NH(+))(a), Ir(0)(n)·(POct(3))(0.2n)(Cl(–)H(+))(b), Ir(0)(n)·(POct(3))(0.2n), and the γ-Al(2)O(3)-supported heterogeneous catalyst, Ir(0)(n)·(γ-Al(2)O(3))(a)(Cl(–)H(+))(b). (where a and b vary for the differently ligated nanoparticles; in addition, solvent can be present as a nanoparticle surface ligand). With added POct(3) as a key, prototype example, an important feature is that a minimum, desired, experimentally determinable amount of ligand (e.g., just 0.2 equiv POct(3) per mole of Ir) can be added, which is shown to provide sufficient stabilization that the resultant Ir(0)(n)·(POct(3))(0.2n)(Cl(–)H(+))(b) is isolable. Additionally, the initial labile ligand stabilizer HCl can be removed to yield Ir(0)(n)·(POct(3))(0.2n) that is >99% free of Cl(–) by a AgCl precipitation test. The results provide strong support for the weakly ligated, labile ligand nanoparticle concept and specific support for Ir(0)(n)·(H(+)Cl(–))(a) as a WLLL nanoparticle. American Chemical Society 2018-11-01 /pmc/articles/PMC6643726/ /pubmed/31458138 http://dx.doi.org/10.1021/acsomega.8b01569 Text en Copyright © 2018 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes. |
spellingShingle | Mondloch, Joseph E. Özkar, Saim Finke, Richard G. “Weakly Ligated, Labile Ligand” Nanoparticles: The Case of Ir(0)(n)·(H(+)Cl(–))(m) |
title | “Weakly Ligated, Labile Ligand” Nanoparticles:
The Case of Ir(0)(n)·(H(+)Cl(–))(m) |
title_full | “Weakly Ligated, Labile Ligand” Nanoparticles:
The Case of Ir(0)(n)·(H(+)Cl(–))(m) |
title_fullStr | “Weakly Ligated, Labile Ligand” Nanoparticles:
The Case of Ir(0)(n)·(H(+)Cl(–))(m) |
title_full_unstemmed | “Weakly Ligated, Labile Ligand” Nanoparticles:
The Case of Ir(0)(n)·(H(+)Cl(–))(m) |
title_short | “Weakly Ligated, Labile Ligand” Nanoparticles:
The Case of Ir(0)(n)·(H(+)Cl(–))(m) |
title_sort | “weakly ligated, labile ligand” nanoparticles:
the case of ir(0)(n)·(h(+)cl(–))(m) |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643726/ https://www.ncbi.nlm.nih.gov/pubmed/31458138 http://dx.doi.org/10.1021/acsomega.8b01569 |
work_keys_str_mv | AT mondlochjosephe weaklyligatedlabileligandnanoparticlesthecaseofir0nhclm AT ozkarsaim weaklyligatedlabileligandnanoparticlesthecaseofir0nhclm AT finkerichardg weaklyligatedlabileligandnanoparticlesthecaseofir0nhclm |